Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab
Clinical trial NCT07100704 · RECRUITING
Trial details
- NCT number
- NCT07100704
- Sponsor
- National Cancer Center Hospital East
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2028-04-14
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.